American Cannabis Company, Inc. (AMMJ) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAmerican Cannabis Company, Inc. (AMMJ) trades at $0.0004. American Cannabis Company, Inc. provides consulting services and products to businesses in the regulated cannabis and hemp industries in the United States and Canada. Sector: Industrials.
Price as of Sep 11, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for AMMJ: AMMJ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AMMJ against Industrials peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
Dated analysis: the newest financial statements on file are 30 months old (Mar 1, 2024), so the figures and score below describe that period, not today.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
AMMJ: 1/2 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
American Cannabis Company, Inc. (AMMJ) Industrial Operations Profile
American Cannabis Company, Inc. offers consulting and product solutions for the cannabis and hemp industries, providing services from business planning to regulatory compliance, and selling cultivation equipment like the Satchel and SoHum Living Soil. The company operates in the US and Canada.
What Is the Investment Thesis for AMMJ?
American Cannabis Company, Inc. presents a speculative investment opportunity within the evolving cannabis industry. The company's consulting services and product offerings cater to a niche market, providing potential for growth as the cannabis industry expands. However, the company's small size, as indicated by its $0.00B market cap and negative profit margin of -147.8%, suggests significant financial risks. The negative beta of -1.70 indicates an inverse correlation with the market, which may offer some diversification benefits but also reflects the company's unique risk profile. Investors should carefully consider the company's financial standing and the competitive landscape before investing. Key catalysts include the expansion of cannabis legalization and the successful adoption of their cultivation products.
Based on FMP financials and quantitative analysis
AMMJ Key Highlights
Market Cap of $0.00B indicates a micro-cap company with high growth potential but also significant risk.
- Negative P/E ratio of -0.01 reflects the company's current lack of profitability.
- Profit Margin of -147.8% highlights significant challenges in achieving profitability.
- Gross Margin of 42.1% suggests a solid foundation for profitability if operational efficiencies improve.
- Negative Beta of -1.70 indicates an inverse correlation with the market, potentially offering diversification benefits.
Who Are AMMJ's Competitors?
AMMJ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| EPOW Sunrise New Energy Co., Ltd. | $0.33 | -7.50% | $9.56M | 479-signal |
| GRNQ Greenpro Capital Corp. | $11.76 | -11.11% | $21.3M | — |
| AERT Aeries Technology, Inc. | $6.78 | +1.04% | $38.9M | 825-pillar |
| RYOJ rYojbaba Co., Ltd. | $4.75 | +1.06% | $54.9M | 565-pillar |
| RGP Resources Connection, Inc. | $3.89 | +0.52% | $134M | 345-pillar |
| FORR Forrester Research, Inc. | $11.84 | -1.66% | $230M | 555-pillar |
| SBC SBC Medical Group Holdings Incorporated | $4.44 | +0.91% | $457M | 925-pillar |
| ROMA Roma Green Finance Limited | $9.44 | +5.14% | $562M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are AMMJ's Key Strengths?
Specialized expertise in the cannabis and hemp industries.
- Proprietary products for cultivation and processing.
- Comprehensive consulting services covering various stages of business development.
- Strategic partnerships within the cannabis industry.
What Are AMMJ's Weaknesses?
Small market capitalization and limited financial resources.
- Negative profit margin and reliance on external funding.
- Limited number of employees.
- Dependence on the evolving regulatory landscape of the cannabis industry.
What Could Drive AMMJ Stock Higher?
Expansion of cannabis legalization in additional states and countries, increasing demand for consulting services.
- Development and launch of new products for cannabis cultivation and processing.
- Strategic partnerships and acquisitions to expand service offerings and market reach.
What Are the Key Risks for AMMJ?
Financial-distress signal — its Altman Z-Score of -15.85 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Increasing competition from larger consulting firms and cannabis companies.
- Evolving regulations and potential changes in cannabis laws.
- Small market capitalization and limited financial resources.
- Negative profit margin and reliance on external funding.
- Negative perceptions and social stigma associated with cannabis.
What Are the Growth Opportunities for AMMJ?
- Expansion of Consulting Services: The increasing legalization of cannabis in more states and countries presents a significant opportunity for American Cannabis Company to expand its consulting services. By offering expertise in licensing, regulatory compliance, and business planning, the company can attract new clients entering the cannabis market. The market for cannabis consulting services is projected to grow as more jurisdictions legalize cannabis, offering a substantial revenue opportunity for AMMJ.
- Product Innovation and Development: Investing in research and development to create innovative products for cannabis cultivation and processing can drive growth. Developing proprietary technologies or unique solutions can differentiate American Cannabis Company from competitors and attract customers seeking cutting-edge solutions. The market for cannabis cultivation equipment is expected to expand, providing a favorable environment for product innovation.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with other companies in the cannabis industry can expand American Cannabis Company's reach and service offerings. Acquiring complementary businesses can also provide access to new markets and technologies. These partnerships can create synergies and enhance the company's competitive position.
- International Expansion: As cannabis legalization spreads globally, American Cannabis Company can explore opportunities to expand its operations into new international markets. Offering consulting services and products tailored to the specific regulatory environments of different countries can drive growth and diversify revenue streams. This expansion requires careful consideration of local laws and regulations.
- Focus on Hemp Industry: With the growing demand for hemp-derived products, American Cannabis Company can capitalize on this trend by offering specialized consulting services and products for hemp cultivation and processing. The hemp industry presents a significant growth opportunity, particularly in areas such as CBD production and industrial hemp applications. Focusing on this sector can diversify the company's revenue streams and reduce its reliance on the cannabis market.
What Are AMMJ's Competitive Advantages?
- Specialized Expertise: Deep understanding of the cannabis and hemp industries, providing valuable insights and guidance to clients.
- Proprietary Products: Unique products like The Satchel and SoHum Living Soil offer a competitive advantage.
- Regulatory Knowledge: Expertise in navigating the complex regulatory landscape of the cannabis industry.
- Established Partnerships: Strategic partnerships with other companies in the industry enhance service offerings and market reach.
What Does AMMJ Do?
Founded in 2013, American Cannabis Company, Inc. provides solutions for businesses operating within the regulated cannabis industry across the United States and Canada. The company, along with its subsidiary Hollister & Blacksmith, Inc., offers a suite of consulting services tailored to cannabis and hemp businesses at various stages of development. These services encompass business planning, license application support, growth strategy development, and ongoing monitoring. Additionally, American Cannabis Company provides cultivation build-out oversight, cannabis regulatory compliance assistance, and compliance audit services. Beyond consulting, American Cannabis Company sells products and equipment essential for cannabis cultivation, processing, transportation, and retail. Key products include The Satchel, a child-proof exit package; SoHum Living Soil, a just-add-water soil solution; the High Density Cultivation System, designed for efficient space utilization; and The Cultivation Cube, a scalable cultivation system. The company also offers advisory services for designing industry-specific products and facilities, and manages a strategic partnership offering commonly used customer products.
What Products and Services Does AMMJ Offer?
- Provides consulting services for cannabis and hemp businesses.
- Assists with cannabis and hemp business planning.
- Supports license applications for cannabis businesses.
- Develops growth strategies for cannabis companies.
- Offers cultivation build-out oversight services.
- Provides cannabis regulatory compliance and audit services.
- Sells products and equipment for cannabis cultivation and processing.
- Offers advisory services for designing industry-specific products and facilities.
How Does AMMJ Make Money?
- Generates revenue through consulting fees for services provided to cannabis and hemp businesses.
- Sells cultivation products and equipment, such as The Satchel and SoHum Living Soil.
- Offers advisory services for designing industry-specific products and facilities.
- Manages a strategic group partnership that offers customer products commonly used in the industry.
What Industry Does AMMJ Operate In?
American Cannabis Company operates in the rapidly evolving cannabis industry, which is experiencing significant growth due to increasing legalization and acceptance. The market is becoming increasingly competitive, with numerous companies offering similar consulting services and cultivation products. The company's success depends on its ability to differentiate itself through specialized expertise, innovative products, and effective marketing. The industry is subject to evolving regulations, creating both opportunities and challenges for companies like American Cannabis Company.
Who Are AMMJ's Key Customers?
- Cannabis cultivators and growers.
- Cannabis processors and manufacturers.
- Cannabis dispensaries and retailers.
- Hemp farmers and processors.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 577 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 41 |
| 2026-08-26 | 41 |
| 2026-08-29 | 41 |
| 2026-09-01 | 41 |
| 2026-09-04 | 41 |
| 2026-09-07 | 41 |
| 2026-09-10 | 41 |
What changed?
The score has stayed at 41.
Over the same 18 days the stock moved -20.0%.
Insider Activity
The most recent 12 insider filings for American Cannabis Company, Inc. break down as 1 sales and 11 purchases. On net that is roughly 28.3M shares acquired (about $570K) — insiders putting money in tends to read as conviction.
Quarterly Financial Performance: American Cannabis Company, Inc.
Revenue for American Cannabis Company, Inc. came in at $432K during Q2 FY2024, a 68.8% improvement versus the preceding quarter. The company recorded a net loss of $636K, with diluted EPS of $-0.00.
Key Financial Metrics
Its free cash flow yield is -88.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.42 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
American Cannabis Company, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -15.85 places it in the distress zone, a signal of elevated financial risk.
Company Profile
American Cannabis Company, Inc. operates in the Specialty Business Services industry within the Industrials sector. It is headquartered in Colorado Springs, US. The company is led by CEO James Woodend. AMMJ has traded publicly since 2014.
AMMJ Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Specialized expertise in the cannabis and hemp industries.
- Proprietary products for cultivation and processing.
- Comprehensive consulting services covering various stages of business development.
- Strategic partnerships within the cannabis industry.
Bear Case
- Small market capitalization and limited financial resources.
- Negative profit margin and reliance on external funding.
- Limited number of employees.
- Dependence on the evolving regulatory landscape of the cannabis industry.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2024 | $431,878 | -$636,000 | -$0.0034 |
| Q1 FY2024 | $255,821 | -$132,551 | -$0.0007 |
Q2 FY2024 · filed 11 Feb 2025 · SEC EDGAR →
Based on FMP financials and quantitative analysis
AMMJ Latest News
-
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
Yahoo! Finance: AMMJ News · Aug 20, 2026
-
Stocks That Hit 52-Week Lows On Monday
· Dec 23, 2019
-
Stocks That Hit 52-Week Lows On Thursday
· Dec 19, 2019
-
Stocks That Hit 52-Week Lows On Monday
· Nov 18, 2019
AMMJ Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AMMJ.
Price Targets
Wall Street price target analysis for AMMJ.
AMMJ MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AMMJ; grades run from A+ (80-100) to F (below 30).
Latest News
TerrAscend Announces Renewal and Replenishment of $10 Million Share Repurchase Program
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Monday
Leadership: Joseph Cleghorn
CEO
Joseph Cleghorn serves as the CEO of American Cannabis Company, Inc. His background includes experience in business management and strategic development within emerging industries. He has focused on building the company's consulting services and product offerings to meet the needs of the regulated cannabis industry. His leadership is centered on innovation and compliance within the evolving cannabis market.
Track Record: Under Joseph Cleghorn's leadership, American Cannabis Company has focused on providing comprehensive solutions for cannabis businesses. Key achievements include the development of proprietary products like The Satchel and SoHum Living Soil. Strategic decisions have centered on expanding the company's consulting services and navigating the complex regulatory landscape of the cannabis industry. The company manages a small team of 4 employees.
AMMJ OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that American Cannabis Company may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and operational performance. This tier is often associated with higher risk and greater potential for volatility compared to companies listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Limited Financial Disclosure: OTC companies often have less stringent reporting requirements, making it difficult to assess their financial health.
- Liquidity Risk: Lower trading volumes can lead to wider bid-ask spreads and difficulty in executing trades.
- Regulatory Scrutiny: OTC markets are subject to less regulatory oversight, increasing the risk of fraud and manipulation.
- Going Concern Risk: Companies trading on the OTC Other tier may face financial difficulties and potential bankruptcy.
- Valuation Uncertainty: Limited information and liquidity can make it challenging to accurately value OTC stocks.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's liquidity and trading volume.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Check for any regulatory actions or legal issues involving the company.
- Company has been in operation since 2013.
- Provides consulting services and products to the regulated cannabis industry.
- Has a subsidiary, Hollister & Blacksmith, Inc.
- Offers a range of products and services, including The Satchel and SoHum Living Soil.
- CEO is identified as Joseph Cleghorn.
American Cannabis Company, Inc. Industrials Stock: Key Questions Answered
Is AMMJ a good stock?
Stock Expert AI does not rate AMMJ buy, sell or hold. American Cannabis Company, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What are the main risks for AMMJ?
American Cannabis Company, Inc. faces several risks, including its small market capitalization, negative profit margin, and dependence on the evolving regulatory landscape of the cannabis industry. Increasing competition from larger consulting firms and cannabis companies poses a threat to its market share.
What are the key factors to evaluate for AMMJ?
Evaluate AMMJ on fundamentals, analyst consensus, and risk factors. Market Cap of $0.00B indicates a micro-cap company with high growth potential but also significant risk. Not financial advice.
How frequently does AMMJ data refresh on this page?
AMMJ's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven AMMJ's recent stock price performance?
American Cannabis Company, Inc. (AMMJ) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in the cannabis and hemp industries. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AMMJ overvalued or undervalued right now?
American Cannabis Company, Inc. (AMMJ) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of AMMJ?
Yes, most major brokerages offer fractional shares of American Cannabis Company, Inc. (AMMJ) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track AMMJ's earnings and financial reports?
American Cannabis Company, Inc. (AMMJ) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for AMMJ earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is limited and may not be fully up-to-date.
- OTC market investments carry significant risk.